Scharf Investments’s Allergan Inc AGN Stock Holding History

Scharf Investments’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-970,607	Closed	-$206M	–	57
2014 Q4	$206M	Buy	970,607 +52,544	+6%	+$10.4M	6.2%	1
2014 Q3	$164M	Buy	918,063 +85,075	+10%	+$14.1M	5.78%	1
2014 Q2	$141M	Buy	832,988 +8,962	+1%	+$1.4M	5.48%	1
2014 Q1	$102M	Sell	824,026 -143,779	-15%	-$17.5M	4.55%	11
2013 Q4	$108M	Sell	967,805 -33,445	-3%	-$3.19M	4.81%	1
2013 Q3	$90.6M	Buy	+1,001,250	New	+$89.9M	4.28%	14

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Scharf Investments's AGN Position: Q1 2015 in Review

Scharf Investments sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 970,607 shares — an estimated $206M sold.

Scharf Investments first reported a position in AGN in Q3 2013 and held it in 6 quarters. The position peaked at $206M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Scharf Investments reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Scharf Investments sold 970,607 Allergan Inc shares in Q1 2015, an estimated $206M.
Scharf Investments first reported a position in Allergan Inc in Q3 2013 and held it in 6 quarters.
Scharf Investments's Allergan Inc position peaked at $206M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Scharf Investments's 13F filing for Q1 2015, filed 14 May 2015.